Table: Phoenixbio -Q1 group results

PhoenixBio

10/08/2017 08:00

Aug 10 (Reuters)-  
             Phoenixbio Co., Ltd.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              123 mln             337 mln           1.48      
                   (-63.4 pct)                          (+20.5 pct)  
  Operating       loss 136 mln           50 mln           263 mln    
                                                        (+85.4 pct)  
  Recurring       loss 138 mln            4 mln           262 mln    
                                                        (+96.8 pct)  
  Net             loss 138 mln            3 mln           232 mln    
                                                        (+80.9 pct)  
  EPS            loss 48.03 yen         1.13 yen         80.36 yen   
  EPS Diluted                           1.10 yen                     
  Ann Div                                  NIL              NIL      
  -Q2 div                                  NIL              NIL      
  -Q4 div                                  NIL              NIL      
   
  NOTE - Phoenixbio Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T  
  ((Tokyo Headline News Desk +813 6441 1812))